US

Uppuluri Srilakshmi

Active Director Director DIN 07790524
DIN 07790524 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value •••• Premium profile

About Uppuluri Srilakshmi

Data last updated:

Uppuluri Srilakshmi is a Director at Vgs Synthesis Private Limited (since 2017). The company operates in Pharma. Vgs Synthesis Private Limited reported revenue of ₹6.22 Cr (FY 2023).

DIN 07790524
Primary Designation Director
Industry Pharma
First Appointment 13 Apr 2017
Oldest Company Age 9 yrs
Largest company Vgs Synthesis Private Limited · ₹6.22 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vgs Synthesis Private Limited U24304TG2017PTC116524
Director13 Apr 20172017₹6.22 Cr (FY 2023)Active

Board colleagues of Uppuluri Srilakshmi

Directorship timeline

Open interactive timeline →
Vgs Synthesis Private Limited
Premium access

Shareholding and investment profile for Uppuluri Srilakshmi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uppuluri Srilakshmi

Uppuluri Srilakshmi currently holds 1 directorship: Vgs Synthesis Private Limited (Director, since 13 Apr 2017, revenue ₹6.22 Cr (FY 2023)).

Uppuluri Srilakshmi was first appointed on 13 Apr 2017 as Director at Vgs Synthesis Private Limited.

The current boards of Uppuluri Srilakshmi's companies include Gopalachowdary Veera Venkata Uppuluri (Vgs Synthesis Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available